Seeking Alpha

Protagonist Therapeutics: Two 'Slam Dunk' Sets Of Pivotal Data Set Up Bull Case

Protagonist Therapeutics has delivered strong Phase 3 data for both icotrokinra (psoriasis) and rusfertide (polycythemia vera), supporting blockbuster potential. Lucrative partnerships with Johnson & ...
Seeking Alpha

Protagonist Therapeutics: Why I Remain On Sidelines Despite Obvious Promise

Protagonist Therapeutics' stock has experienced significant volatility over the past three years, with multiple setbacks and recoveries. The company's lead drug candidate, Rusfertide, indicated for ...
Deadline.com

Protagonist Pictures Promotes Janina Vilsmaier & Mounia Wissinger; Bolsters Sales & Marketing Teams Ahead Of EFM

Protagonist Pictures has promoted senior execs Janina Vilsmaier and Mounia Wissinger to senior leadership roles as part of a wider move to strengthen its sales and marketing teams. Vilsmaier has been ...
Variety

Protagonist Launches Specialist Label Ahead of Cannes With Slate Including Vice Doc, Lucien Laviscount Rom-Com and Paul Walter Hauser, Walton Goggins Drama (EXCLUSIVE)

London-based sales, finance and production company Protagonist Pictures has launched a boutique label on the eve of Cannes. Announced by Protagonist CEO Dave Bishop, Protagonist Picks will be led by ...
Benzinga.com

Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report

Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to acquire Protagonist Therapeutics (NASDAQ:PTGX). Citing people close to the talks, the Wall Street Journal reported that the deal is not ...